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The transformation-associated region of herpesvirus saimiri strains is variable, whereas other parts of the virus genome
are highly conserved. However, we observed considerable interstrain sequence divergence of the early viral regulatory orf50
gene, which encodes the R transactivator, a homolog of Epstein–Barr virus BRLF1. The orf50 gene of strain C488 was
transcribed at low abundance during lytic infection, whereas antisense transcripts were simultaneously expressed at high
levels. A spliced variant, orf50a, was detectable by RT-PCR and RNase protection assays in stimulated C488-transformed,
nonpermissive human T cells. In contrast to strain A11, the short, unspliced orf50b form of C488 displayed complete
transactivation capability on the orf6 and orf57 promoters. In summary, there are unexpected structural and functional
differences between the orf50 genes of herpesvirus saimiri strains, which differ in their capability to transform human T
lymphocytes. © 2000 Academic Press
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(INTRODUCTION
Squirrel monkeys (Saimiri sciureus) are naturally and
persistently infected by herpesvirus saimiri (HVS; saimiri-
ine herpesvirus type 2), a g2-herpesvirus which does not
ause any disease in this host. However, if the virus is
xperimentally transferred to other New World primates,
ncluding common marmosets (Callithrix jacchus) or cot-
ontop tamarins (Saguinus oedipus), the animals develop
cute T-cell lymphoma within a few weeks. HVS strains
ave been assigned to three subgroups, A, B, and C,
epending on the transforming and pathogenic capabil-
ty and sequence divergence of a terminal region of the
iral L-DNA (Medveczky et al., 1984, 1989). In strain 11 of
ubgroup A, the gene for the saimiri-transforming protein
stpA) was identified in this terminal position. Deletion of
his gene rendered the virus nonpathogenic and non-
ransforming (Desrosiers et al., 1984, 1985, 1986; Koomey
t al., 1984). The virus strain 488 of subgroup C carries
wo genes at this position: stpC and a gene coding for
he tyrosine kinase interacting protein (Tip), which inter-
cts with the T-cellular protein kinase Lck (Biesinger et
l., 1990, 1995). Both stpA and stpC have been shown to
ncode transforming proteins (Jung et al., 1991). In con-
rast to virus strain A11, C488 is capable of transforming
uman T cells to stable growth in culture (Biesinger et al.,
992). In these cells, the virus persists episomally with-
ut virion production and with restricted virus gene ex-
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 49-9131-85-26493. E-mail: fickenscher@viro.med.uni-
rlangen.de.
167ression (Biesinger et al., 1992; Fickenscher et al., 1996;
nappe et al., 1997). Deletion of stpC and tip of C488
abolishes the transforming capability for human and sim-
ian T cells, and the induction of T-cell lymphoma in
common marmosets (Knappe et al., 1997; Duboise et al.,
998a). The rest of the virus genome was assumed to be
ighly conserved among different virus strains (Med-
eczky et al., 1984, 1989). For example, sequence analy-
is of a 16-kb gene block from orf12 to orf25 of C488
revealed a high degree of conservation, ranging from 85
to 99% amino acid identity (Albrecht et al., 1992; Knappe
t al., 1997). However, only virus strain A11 has been
ntirely sequenced (Albrecht et al., 1992).
Besides the transforming genes stpC and tip of C488,
e were interested in the viral regulatory genes and their
ole in virus replication and T-cell transformation. There
re only three likely candidates for genes which might
egulate replication in HVS (Nicholas et al., 1990, 1991).
he first is the major immediate-early gene orf14, which
s highly conserved between A11 and C488 (95%); orf14
s the third transformation-associated virus gene in
ransformed human T cells (Knappe et al., 1997) and
ncodes a superantigen-homologous mitogen for T cells
Yao et al., 1996). This gene is dispensable for virus
replication in vitro and in cottontop tamarins, and is
probably unrelated to replication regulation (Nicholas et
al., 1990; Knappe et al., 1997; Duboise et al., 1998b).
Moreover, deletion of this gene did not affect the trans-
formation of human T cells. Its role in transformation of
simian T cells and pathogenicity is variable, depending
on the primate species analyzed (Knappe et al., 1997,
1998; Duboise et al., 1998b). The second immediate-early
0042-6822/00 $35.00
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168 THURAU ET AL.gene (orf57) is conserved at the amino acid level (Nich-
olas et al., 1990; Knappe et al., 1997). In transformed
uman T cells, weak transcription was detectable after
horbolester stimulation (Knappe et al., 1997); orf57 is
omologous to IE63/ICP27 of herpes simplex virus, and
as been shown to redistribute spliceosome compo-
ents and to suppress the expression of spliced viral
ranscripts (Whitehouse et al., 1998b; Cooper et al., 1999).
The third viral regulatory gene candidate is the early
gene orf50, which encodes a transactivator related to the
BRLF1 product Rta of Epstein–Barr virus (EBV). The orf50
gene product of strain A11 has been shown to transac-
tivate delayed-early virus promoters and to activate tran-
scription of the orf57 splicing regulator gene. Two differ-
ent mRNAs are transcribed from the orf50 gene: a long,
spliced transcript (orf50a), which can be detected early
in infection and causes strong transactivation, and a
shorter, unspliced transcript (orf50b), which only weakly
transactivates promoters of other HVS genes (Nicholas
et al., 1991; Whitehouse et al., 1997a,b, 1998a).
In this study, we performed a structural and functional
analysis of the orf50 gene of strain C488, which is capa-
le of transforming human T cells in culture. Unexpect-
dly, we observed a marked sequence divergence in the
rf50 gene between virus strains A11 and C488. This
enomic region was found to be heavily transcribed
uring replication, predominantly in the antisense orien-
ation. In transformed human T lymphocytes, we showed
hat orf50 is inducibly transcribed after phorbolester
timulation. In addition, the observed sequence diver-
ence results in proteins with altered transactivation
roperties, which seem to assign the dominant regula-
ory function to orf50b in strain C488.
RESULTS
equence divergence between the orf50 genes of
VS strains C488 and A11
The genomic orf50 region of the virus strain C488 was
equenced from a library of overlapping HindIII and XbaI
ragment plasmids (Knappe et al., 1997), resulting in a
171-nucleotide (nt) sequence named 488R. Sequence
omparison of the C488 and A11 orf50 regions revealed
considerable divergence between strains C488 and
11 (Table 1, Fig. 1). However, the overall gene structure
as preserved. The predicted spliced structure of orf50a
as confirmed by RT-PCR (primers HF317/HF377) and
DNA sequencing, using RNA from infected OMK cells.
hereas ORF49 was conserved to 95% at amino acid
evel, only 60% identity was observed for the whole
RF50b. When the 250 C-terminal amino acids of the
RF50b were compared separately, the identity was only
9%. The degree of conservation is similar between both
VS strains and herpesvirus ateles. However, the re-
pective proteins of rhesus monkey rhadinovirus, humanerpesvirus type 8, and EBV are only distantly related
Fig. 1C).
Strain A11 ORF50b has potential start codons at nt
ositions (pos.) 71188 and 71353. In strain C488, the first
nitiation codon is missing, whereas the second is con-
erved at pos. 1638 (488R). In vitro transcription and
ranslation experiments using T7 polymerase and reticu-
ocyte lysates demonstrated a protein of approximately
4 kDa derived from the spliced orf50a cDNA (predicted
ize: 58 kDa). In addition, a smaller protein was pro-
uced, with both the spliced orf50a cDNA plasmid and
ith a genomic clone of orf50b (Fig. 2). The apparent
rotein size of 45 kDa (predicted size: 38 kDa) is com-
atible with the putative start site at pos. 1638 in 488R,
orresponding to pos. 71353 in A11.
ranscription of the orf50 region of C488
Transcription of the C488 orf50 region was studied
after infection of OMK cells at a multiplicity of infection
(m.o.i.) of approximately 4. Total cellular RNA was har-
vested at 8, 24, or 48 h after infection. At 72 h postinfec-
tion, the cytopathogenic effect had already led to signif-
icant loss of cells and poor RNA yields. Northern blot
hybridization with a random-primed, double-stranded
DNA probe for orf50b (pos. 982 to 2902 in 488R) demon-
strated strong signals at unexpected band sizes of about
5.0, 3.7, and 2.9 kb, mainly at 48 h postinfection (Fig. 3A).
Rehybridization with an in vitro transcribed, single-
stranded antisense riboprobe of orf50b yielded ex-
tremely weak signals of about 1.2, 1.6, and 1.9 kb, which
were confirmed by probing a blot carrying purified poly-
adenylated RNA (Fig. 3B). On rehybridization using a
sense-oriented, single-stranded orf50b RNA probe, the
TABLE 1
Sequence Conservation of C488 with A11 Genes
Virus gene (C488)
Nucleotides Amino acids
Number Identity (%)a Number Identity (%)a
orf49 909 96.0 303 94.7
orf50, exon 1 21 95.2 7 85.7
orf50, exon 2 1539 77.2 513 69.4
orf50a 1560 77.4 520 69.6
orf50b 1044 71.6 348 60.0
orf50b, C-terminal 750 66.0 250 49.4
orf6 promoter 1044 75.2 – –
orf36 promoter 1009 97.5 – –
orf44 promoter 664 98.8 – –
orf57 promoter 1729 98.3 – –
a Sequence comparison with HVS A11 using the GCG program gap.hybridization patterns with the double-stranded DNA
probe were confirmed (Fig. 3C), which indicates that
(C) The ORF50 proteins and their homologs of other gammaherpesvi-
ruses were compared using the GCG program gap. The sequence
169R TRANSACTIVATOR OF HERPESVIRUS SAIMIRI C488most transcripts from this region are oriented in the
antisense direction with respect to orf50.
To further analyze transcription of the orf50 region,
RT-PCR experiments were designed to amplify the 59
ends of transcripts. Initial experiments used a published
tailing method (Whitehouse et al., 1997a) with primer
HF184, which is directed upstream and binds to the
central portion of orf50b. Two main PCR product species
were generated which hybridized to a double-stranded
orf50b DNA probe (data not shown). The pattern seemed
similar to the observations made previously for strain
A11 (Whitehouse et al., 1997a). However, sequencing
revealed that the larger product represented an un-
spliced fragment starting downstream of orf50a exon 1.
The smaller product represented a spliced version with a
large gap within orf50a exon 2, and thus did not corre-
spond to the expected splicing pattern, suggesting that it
may represent the antisense transcripts.
Therefore, further experiments for the rapid amplifica-
tion of cDNA ends (RACE) were performed with addi-
tional primers and an improved protocol (Marathon,
Clontech). In 59 and 39 RACE experiments, four different
virus-specific primers were used (HF177, HF181, HF184,
and HF653). Twenty-three representative cDNA clones
were sequenced (Fig. 4). In the first part of the experi-
identity (id%) and similarity (sim%) values are given, when ORF50a/
C488 was compared to the respective proteins derived from the se-
quences of HVS A11 (X64346), herpesvirus ateles (HVA; AF083424),
FIG. 2. In vitro translation products of orf50. The products of in vitro
transcription/translation reactions using T7 polymerase and reticulo-
cyte lysates were separated on an SDS/polyacrylamide (12%) gel and
subjected to autoradiography. Plasmid p50a contains the spliced cDNA
of orf50a. Plasmid p50b harbors orf50b together with its native pro-
moter. A major band of about 64 kDa (predicted size: 58 kDa) is
generated by p50a. A minor band of about 45 kDa (predicted size: 38
kDa) is identical for p50a and p50b and argues for the usage of the
common start codon at pos. 1638 in 488R. M, marker.FIG. 1. Sequence divergence between the orf50 genomic regions of
HVS strains A11 and C488. (A) The localization and orientation of the
open reading frames is given on top. The orf50 region nucleotide
sequences of both virus strains (C488: 488R/AJ131935; A11: X64346)
were aligned with the GCG programs bestfit, pileup, and plot similarity.
The graph represents the local homology, when flanking stretches of
200 nt were tested. (B) The ORF50b amino acid sequences of strain
C488 (upper) and A11 (lower) were aligned using the GCG program
gap. Whereas there is high sequence conservation within the first 100
amino acids, the remaining part of the protein is much more divergent.rhesus monkey rhadinovirus (RRV; AF083501), human herpesvirus type
8 (HHV8; U75698), and human Epstein–Barr virus (EBV; V01555).
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170 THURAU ET AL.ment, RNA from lytically infected OMK cells was used.
Two of the 59 RACE clones (1, spliced; 2, unspliced)
carried a polyT stretch at their 59 ends, suggesting that
these transcripts had an antisense orientation to orf50
nd served orf49. Clones 1 and 2 were identical to the
DNAs previously obtained by the tailing strategy. The 39
ACE clones 6 and 7 confirmed the presence of a splice
cceptor site within exon 2 of orf50a. The respective
plice donor sites and cDNA termini were localized fur-
her downstream, corresponding to orf52 and orf53.
oreover, the 39 RACE clones 11 and 12 indicated that
here were also unspliced transcripts present of the
FIG. 3. Transcription of the orf50 region after infection of OMK cells
by HVS. OMK cells were infected with HVS C488 at a m.o.i. of about 4.
RNA was prepared at 8, 24, or 48 h after infection. Either total or purified
polyadenylated RNA was analyzed by Northern blot hybridization. Panel
A shows the results of hybridization with a double-stranded probe
covering orf50b (pos. 982 to 2902 in 488R). An antisense-oriented
iboprobe of the same fragment was used for panel B, whereas a
iboprobe in sense-orientation was applied in panel C. Ethidium bro-
ide-stained rRNA bands are shown as loading control (panel D).ame orf49 mRNA familiy. Some other unspliced cDNA
clones also seemed to serve orf49 (e.g., 8 and 9). A fewof the unspliced cDNA clones might theoretically encode
orf50b (e.g., 4, 5, and 13). However, as no 39 polyA
stretches were attached, it is more likely, that most of
these cDNA clones represented antisense transcripts to
orf50. This is compatible with the observation that North-
ern blot signals for orf50 were far weaker as compared to
he antisense transcripts.
In additional 59 RACE experiments, RNA was utilized
rom transformed human T cells (CB-15) which had been
timulated with phorbolester (tetradecanoyl phorbol ac-
tate [TPA], 2 ng/ml for 6 h) (Biesinger et al., 1992;
ickenscher et al., 1996; Knappe et al., 1997; Fickenscher
nd Fleckenstein, 1998). The resulting cDNA clones 16
nd 17 showed the expected splice pattern for orf50a.
lones 21–23 corresponded to the described position of
he orf50b promoter (Whitehouse et al., 1997a). Three
other cDNA clones (18–20) suggested an additional pro-
moter near the start of exon2. These cDNAs have the
coding capacity for orf50b, since there is no further
initiation codon present upstream of pos. 1638. Anti-
sense transcripts were not detectable in nonpermissive,
transformed human T cells. The three groups of cDNAs
correspond well to the three orf50 transcripts of 1.2, 1.6,
and 1.9 kb observed during lytic replication (Fig. 3B).
Transcription of orf50a during lytic replication and in
transformed human T cells
Because the cDNA cloning experiments revealed a
complex transcription pattern, orf50a transcription was
specifically analyzed by RT-PCR, using the predicted
splicing pattern (Whitehouse et al., 1997a). As an internal
control, RT-PCR for glyceroyl aldehyde phosphate dehy-
drogenase (gapdh) was performed. The 59 primers
HF317 (C488) and HF463 (A11) are situated within exon 1
of orf50a, whereas the 39 primers HF182 (C488) and
HF464 (A11) are located in the second exon. The kinetics
of orf50a expression were studied after infection of OMK
cells by HVS C488 or A11 at m.o.i. of approximately 4.
Transcripts of orf50a were detectable starting at 8 h
postinfection. No significant differences were noted be-
tween strains C488 and A11 (Fig. 5A).
Moreover, the transformed human T-cell lines CB-15
(CD41) and 3C (CD81) were analyzed by orf50a RT-PCR
without or with additional stimulation by 2 ng/ml TPA for
6 h. RT-PCR was performed with two different primer
pairs (Fig. 5B: upper panel, HF317/HF180; lower panel,
HF317/HF318). Northern blot hybridization with an anti-
sense riboprobe was not sufficiently sensitive to demon-
strate orf50a transcripts. However, whereas background
transcription was not observed, orf50a transcripts were
demonstrated by RT-PCR in transformed human T cells
after phorbolester stimulation.
To provide the formal proof of orf50a transcripts,
RNase protection assays were performed (Fig. 5C). A
fragment of about 350 nt was specifically protected from
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171R TRANSACTIVATOR OF HERPESVIRUS SAIMIRI C488RNase digestion of total RNA samples after hybridization
with a radioactive antisense-oriented riboprobe of 976 nt.
The respective band had strong intensity at 48 and 72 h
postinfection. Weak transcription was confirmed for
phorbolester-stimulated C488-transformed human T
cells. Thus the transcript start was mapped to approxi-
mately 350 nt upstream of the splice donor site.
Differential transactivation by orf50 genes:
comparison of strains A11 versus C488
The pronounced sequence divergence in the C-termi-
nal portion of orf50b of these strains raised the question
or functional consequences. We cloned and sequenced
series of C488 promoters for ORF50 target genes,
hich had been previously identified in the A11 system
Whitehouse et al., 1997a,b, 1998a,b), that is, the pro-
oter regions of orf6, orf36, orf44, and orf57. Whereas
the orf6 promoters displayed only 75% nucleic acid iden-
tity, the promoters for orf36, orf44, and orf57 were highly
conserved at 97, 99, or 98% identity, respectively (Table
FIG. 4. cDNAs of the orf50 region. Using gene-specific primers (HF1
pper three sets of cDNA clones were generated from RNA of lytically
f phorbolester-stimulated, HVS-transformed, nonproductive human C
hereas the specific primer defines one end of the cDNA clones, the o
ines indicate introns in the cDNA clones 1, 6, 7, 16, and 17. In clones
olyadenylated mRNA. The termini of the cDNA clones 6, 7, 11, and 121).
For further analysis, we chose the divergent orf6 pro-moter and the well-conserved orf57 promoter and cloned
ach upstream of the cat reporter gene. The C488 pro-
oters were generated in the form of cloned fragments
omologous to the respective A11 constructs (pAWCAT2
orf6 promoter], pORF57CAT1 [orf57 promoter]) (White-
house et al., 1997b, 1998a). C488 transactivator plasmids
were constructed corresponding to the PstI (genomic
orf50a and orf50b) and HincII fragments of A11 (orf50b
ith own promoter) as described (pAWPstI [genomic PstI
ragment], pAWHincII [genomic HincII fragment]) (Nicho-
as et al., 1991; Whitehouse et al., 1997a). In addition,
cDNA expression plasmids for orf50a of A11 (pORF50a)
(Whitehouse et al., 1997a) and C488 were used. Each
respective promoter-reporter construct was cotrans-
fected with the transactivator plasmids into OMK cells,
harvested after 48 h, and assayed for CAT activity. Ex-
periments were performed in parallel with A11- and
C488-derived constructs; orf50b of A11 was confirmed to
be a poor activator of heterologous viral promoters com-
pared to orf50a, as previously described (Whitehouse et
81, HF184, HF653), 59 and 39 RACE experiments were performed. The
d OMK cells, whereas the set shown below (16–23) resulted from RNA
cells. The cDNA start and stop pos. are given with nt pos. in 488R.
d is marked by the adapter primer used in the RACE protocol. Dotted
2, the 39 end of the cDNAs is marked by a polyT stretch, reflecting
r downstream of orf50. SA, splice acceptor; SD, splice donor.77, HF1
infecte
D41 T
ther enal., 1997a, 1998a). In contrast, the long genomic, the
cDNA version (both encode orf50a and orf50b simulta-
were s
cells (3
172 THURAU ET AL.neously), or the short genomic version of C488 orf50
alone, reproducibly showed approximately the same
transactivating capability (Fig. 6). This suggests that,
FIG. 5. Expression of orf50a during virus replication and in transform
after infection of OMK cells by HVS C488 or A11 at a m.o.i. of about
whereas the 39 primers HF182 (C488) and HF464 (A11) are localized i
position of the primers and the map of the PCR products is shown as
human T-cell lines CB-15 and 3C after additional stimulation by 2 ng/m
generated by RT-PCR with the primer combination HF317 and HF180. I
graph describes the coordinates of the PCR products. (C) Demonstrate
a radioactive antisense-oriented riboprobe was synthesized using SP
entire riboprobe of 976 nt was shortened to a protected fragment of
upstream of the splice donor site. High amounts of orf50a transcripts
were detected after phorbolester stimulation of transformed human Tunlike in strain A11, orf50b is the major transactivating
protein in C488.DISCUSSION
HVS strains are classified into three subgroups, based
an T cells. (A) The kinetics of orf50a expression is shown by RT-PCR
59 primers HF317 (C488) and HF463 (A11) are situated within exon 1,
econd exon. RT-PCR for gapdh serves as internal control. Below, the
atic drawing. (B) Depicts the expression of orf50a in the transformed
decanoyl phorbol acetate (TPA). The results of the upper panel were
wer panel, primers HF317 and HF318 were used for RT-PCR. Below, a
a transcripts by RNase protection assays. As illustrated by the graph,
polymerase after linearization of the template plasmid with NotI. The
imately 350 nt, which indicates the transcription start site for orf50a
een 48 and 72 h after infection of OMK cells. Low transcript amounts
C, CB-15).ed hum
4. The
n the s
a schem
l tetra
n the lo
s orf50
6 RNA
approxon their transforming ability and terminal L-DNA se-
quence (Medveczky et al., 1984, 1989). Even different
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173R TRANSACTIVATOR OF HERPESVIRUS SAIMIRI C488strains of the same subgroup show some variation in
their transformation-associated genes, leading to differ-
ent phenotypes, e.g., in human T cells transformed with
these viruses (Fickenscher et al., 1997; Lee et al., 1997).
reviously, no significant sequence differences have
een reported for genomic regions other than the trans-
ormation-associated genes. The regions orf12 to orf25,
s well as orf71/vFLIP have been shown to be highly
onserved (Y13183, Knappe et al., 1997; Y13660, Kraft et
al., 1998). We were most surprised, therefore, to note the
pronounced sequence divergence between the orf50
transactivator genes of HVS strains A11 and C488 (Fig. 1,
Table 1). In contrast to A11, C488 is able to transform
human T cells in culture (Biesinger et al., 1992). However,
this observation does not yet allow us to correlate orf50
enotype and transforming capability. Presently, addi-
ional orf50 alleles from 11 new virus isolates are being
equenced. A pronounced correlation between orf50 al-
FIG. 6. Differential transactivation by orf50 genes of strains A11
transfection into OMK cells. Published plasmids for A11 genes and pro
respective counterparts from virus strain C488. The summary of three
The genomic and cDNA orf50a constructs encode both orf50a and or
genomic or cDNA constructs for orf50a had been transfected. Whereas
and orf50b of C488 had similar transactivating capability on the orf6 aeles and the respective virus subgroup has been noted,
hus proposing an association of orf50 alleles and trans-
i
vorming phenotype (Thurau, Wittmann, and Fickenscher,
npublished observations).
In this study, we have shown that the orf50 region is
redominantly transcribed in the antisense orientation
uring lytic replication of HVS C488 (Figs. 3 and 4). These
ntisense transcripts carry orf49, which is not yet func-
ionally characterized. Some of these transcripts are
pliced and initiated far upstream in the orf52/orf53 re-
ion. Whereas orf50a transcripts were shown at 8 h
ostinfection (Fig. 5A), abundant antisense transcription
as clearly delayed, starting at 24 h (Fig. 3). It is note-
orthy that the antisense transcription was observed
nly with strain C488. When the tailing experiment was
reviously performed with strain A11, only orf50 sense
ranscripts were detected (Whitehouse et al., 1997a). We
ere also unable to detect antisense transcripts on
orthern blots from A11-infected OMK cells. Since orf50
s one of only two likely viral replication regulatory genes,
C488. Transactivation studies were performed after lipofectamine
were used (Whitehouse et al., 1997a,b, 1998a) and compared to their
ndent experiments is shown. Standard deviation values are indicated.
elevant differences in transactivation were not observed, when either
of A11 was poor in activating the heterologous viral promoters, orf50a
7 promoters.versus
moters
indepe
f50b. Rt may be conceivable that antisense transcription pro-
ides a regulatory mechanism at later times of lytic
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174 THURAU ET AL.infection. Antisense-mediated regulation has been pre-
viously described, e.g., for the EBV gene BZLF1 and for
the latency-associated transcripts of herpes simplex vi-
rus (Prang et al., 1995; Thompson and Sawtell, 1997;
awtell et al., 1998). Antisense transcription has also
een noted for an immediate-early gene of Marek’s dis-
ase virus (Cantello et al., 1994).
We have clearly demonstrated the presence of spliced
orf50 transcripts soon after lytic infection of permissive
OMK cells (Figs. 5A and 5C). Moreover, we have shown
that orf50 is one of the few virus genes expressed in
transformed human T cells after phorbolester stimulation
(Figs. 5B and 5C). The genes stpC and tip, which are
essential for transformation, show basal transcription
and can be stongly induced by T-cell stimulation (Fick-
enscher et al., 1996, 1997; Knappe et al., 1997). The gene
rf14 is weakly expressed in transformed human T cells
nd is heavily induced after chemical T-cell stimulation.
owever, this gene is not required for transformation of
uman T cells (Knappe et al., 1997). Subtractive cDNA
loning revealed transcription of two other virus genes in
horbolester-stimulated transformed human T cells,
amely thymidylate synthase (ts) and orf57, besides
orf50, the other known viral regulatory gene of HVS.
Neither ts nor orf57 showed basal expression; tran-
scripts were detectable only at low levels after chemical
T-cell stimulation (Knappe et al., 1997). It appears that
orf50 belongs to this small group of genes which can be
induced during the persistent and nonproductive infec-
tion of transformed human T cells. It is noteworthy that
the two replication regulatory genes orf50 and orf57 are
both included in this group. However, the induced ex-
pression of these genes in stimulated C488-transformed
human T cells is not sufficient for virus reactivation, as
numerous experiments have failed to detect signs of lytic
replication (Fickenscher et al., 1996, 1997). The block of
virus replication in transformed human T cells seems to
be localized downstream of the expression of the viral
regulatory genes.
The EBV gene BRLF1, a homolog to HVS orf50, en-
codes the R transactivator (Rta), which is sufficient for
disruption of latency in EBV-permissive B cells and epi-
thelial cells (Zalani et al., 1996; Ragoczy et al., 1998).
Furthermore, the human g2-herpesvirus type 8 (HHV-8/
KSHV) encodes a homologous transactivator, which was
assigned to the immediate-early phase and induces lytic
replication in transformed B cells (Lukac et al., 1998,
1999; Sun et al., 1998, 1999; Zhu et al., 1999). The function
of the HVS orf50 has been extensively studied using the
prototype strain A11. Initially, transactivation of the orf6
promoter by a genomic A11 fragment harboring orf50
was noted (Nicholas et al., 1991). Subsequently, two
variants of orf50 were characterized: orf50a is a spliced
transcript with early expression during virus replication,
and orf50b is a shorter, unspliced transcript with delayed
transcription. The spliced transcript of A11 was much
(
fmore potent than the shorter construct in activating the
orf6 and orf57 promoters (Whitehouse et al., 1997a,
1998a). The target sequence for the transactivator was
narrowed down to a 38-bp fragment within this promoter
and a consensus response motif CCN9GG was sug-
ested (Whitehouse et al., 1997b). The other regulatory
ene of HVS, orf57, is homologous to IE63/ICP27 of
herpes simplex virus and to BMLF1 of EBV; orf57 has
een shown to repress the transactivating capability of
he spliced orf50a on a posttranscriptional level,
hereas the transcript levels of orf50b were slightly
nhanced by orf57 (Whitehouse et al., 1998b). Unlike
rf50b, orf50a was capable of transactivating orf57 ex-
ression (Whitehouse et al., 1998a).
In contrast to these results, similar transactivation
evels on the orf6 and orf57 promoters were noted for the
488-derived transactivators, when either the long
enomic fragment or the cDNA version was used (which
ncode both orf50a and orf50b), or when the short
enomic orf50b fragment was used (Fig. 6). The trans-
ctivation function itself seemed not to be altered be-
ween both virus strains. Correspondingly, the C-terminal
ctivation domain of ORF50 was well conserved with
ome conservative amino acid exchanges when com-
ared to the respective motifs of HVS A-11 or even to
HV8 (Hall et al., 1999; Lukac et al., 1999). Since A11-
ORF50b had been shown to be a poor transactivator, a
mechanism of competitive downregulation of target
genes at delayed times of infection had been postulated
(Whitehouse et al., 1997a, 1998a). This type of negative
regulation is unlikely for strain C488, in which ORF50b is
fully functional and in which ORF50 function should not
be switched off by ORF57-mediated splice regulation
and downregulation of ORF50a. This would lead to the
hypothesis that transactivation by the R product of C488
was mainly carried out by ORF50b independently of
ORF57-mediated downregulation (Fig. 7). Thus, ORF50a
would not critically contribute to the observed transacti-
vation, at least in strain C488. Since the replication ki-
netics of strains A11 and C488 are indistinguishable, we
assume that downregulation of orf50 by orf57 may not be
he critical point for HVS C488 replication. This supports
he idea that transactivation by orf50 forms an early step
in induction of lytic virus replication prior to orf57 func-
tion, a mechanism which is obviously impaired in HVS
C488-transformed human T cells.
MATERIALS AND METHODS
Cloning of C488 genes
Virion DNA of strain C488 was digested with the re-
striction enzymes HindIII and XbaI in parallel reactions.
he resulting library of overlapping fragments was
loned into the Bluescript KS1 vector (Stratagene)Knappe et al., 1997). After terminal sequences of the
ragments had been obtained, a series of plasmids rep-
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175R TRANSACTIVATOR OF HERPESVIRUS SAIMIRI C488resenting the orf50 region were selected and sequenced
on both strands by the dye deoxy terminator method
(ABI). The resulting sequence of 3171 nucleotides was
designated 488R.
The coding part of the spliced orf50a cDNA from C488
as amplified by RT-PCR using the oligonucleotide prim-
rs HF317 (ATG-ACA-CAC-AAG-CCT-G, 59 primer, nt pos.
63 in 488R) and HF377 (GCT-TTA-TTC-ATC-AGT-TAC-
AA-ATC, 39 primer, pos. 2664 in 488R, reverse orienta-
ion [rev.]). A genomic fragment of orf50a, including its
wn promoter similar to the published PstI fragment of
train A11 (Nicholas et al., 1991), was amplified using
F166 (GGA-GCA-TAA-AAT-AAA-GCC-AAC-AG, 59) and
F213 (GTC-AAT-GCT-ATG-TGC-TTG-TAA-TAT-C, 39, rev.).
oth primers are situated outside of the 488R sequence
nd were derived from short sequences obtained from
eighboring plasmid clones. In analogy to the published
incII fragment of A11 (Nicholas et al., 1991), the
enomic fragment representing the unspliced orf50b in-
luding its own promoter was prepared with HF280
GGT-TGA-CTC-AGC-TTA-GG, 59 orf50b, pos. 982 of
88R) and HF281 (TTA-GAA-TAT-CTG-CTA-TAT-TAG-G, 39
rf50b, pos. 2880 of 488R, rev.). PCR fragments were
enerated either with KlenTaq (Clontech) or with Pwo
olymerase (Roche) and subsequently cloned into
CR2.1 or pCR-Blunt vectors (Invitrogen). The orf50a
DNA fragment was also subcloned into the expression
ector pcDNA3 (Invitrogen).
The orf6 promoter region of C488 was amplified with
F265 (AAG-CTT-GAA-AAA-CCA-AAA-GTT-GCT-AAT-G,
9) and HF253 (CCG-CTG-CAG-TGT-TAG-ATG-TGG-ATG-
TT-TGA-GAG, 39, rev.), the orf36 promoter with HF279
(GTC-GAC-GTG-AAG-ACA-CAG-TCA-AG, 59) and HF267
(TCT-AGA-GCC-ATT-GTT-GAG-AGA-TTC, 39, rev.), the
orf44 promoter with HF263 (AAG-CTT-TCT-ACT-GCT-ATA-
TGC-TTG, 59) and HF264 (TCT-AGA-TAG-TTC-TGC-CAT-
TAT-TCC, 39, rev.), and the orf57 promoter with HF328
FIG. 7. Comparative model of gene regulation in the virus strains A1
(Whitehouse et al., 1997a,b, 1998a,b) with the results from this study on
of virus gene regulation, since the mechanism of transactivation block
as arrows, inhibitory functions as dashed lines.(AAG-CTT-CAG-ATA-ATA-TCC-ATT-TTG-TCC-CAG, 59) and
HF327 (AAG-CTT-GGC-AGT-TGT-TCA-CCA-TAG, 39, rev.).
T
TPlasmid clones of all PCR products were sequenced and
found to be identical to the respective DNA sequence
derived from the plasmid library (Knappe et al., 1997).
The orf6 and orf57 promoters were inserted into the
pCAT-Basic reporter vector (Promega).
The nucleotide sequences of HVS C488 described in
this report are available under accession numbers
AJ131935 (488R, orf50 region), AJ131936 (orf6 promoter),
AJ131937 (orf36 promoter), AJ131938 (orf44 promoter),
nd AJ131939 (orf57 promoter) in the EMBL sequence
ibrary.
ranscript analysis
Total cellular RNA was prepared by the acidic phenol
ethod (Chomczynski and Sacchi, 1987). Polyadenylated
NA was purified from total RNA with oligo-dT Dyna-
eads (Dynal). Reverse-transcription was performed with
uperscript II (Gibco) and either random hexamer or
ligo-dT primers. To demonstrate orf50a transcription,
T-PCR was performed using the following primers:
F317 (ATG-ACA-CAC-AAG-CCT-G, 59, pos. 163 in 488R),
F180 (CTG-CAA-TTT-GTA-GGC-ACT-C, 39, pos. 1296 in
88R, rev.), HF182 (GTC-CCA-TTA-ACA-CGC-TTT-TTT-C,
9, pos. 1623 in 488R, rev.), HF318 (CTA-AAG-TTG-TAG-
TA-CTA-TTC-C, 39, pos. 1689 in 488R, rev.), HF463 (CAA-
GA-CAC-ACA-AGC-TTG, 59, pos. 69876 in A11), and
F464 (TCC-CAT-TAA-CAC-ACT-TTT-TTC, 39, pos. 71338
n A11, rev.). As an internal control, RT-PCR for glyceroyl
ldehyde phosphate dehydrogenase (gapdh) was per-
ormed with HF147 (GCA-GGG-GGG-AGC-CAA-AAG-GG,
9) and HF148 (TGC-CAG-CCC-CAG-CGT-CAA-AG, 39,
ev.).
Experiments for the rapid amplification of cDNA ends
RACE) were performed with the Marathon kit (Clontech)
nd with the primers HF177 (CAC-CAT-TCG-TAA-AAT-
CA-CC, pos. 364 in 488R), HF181 (CAT-ACA-ACG-CCT-
C488. The figure compares the published observations for strain A11
strain C488. Orf50 seems to play a more central role in the regulation
ORF50b is not active in strain C488. Stimulatory effects are indicated1 and
virusGT-CTA-C, pos. 1472 in 488R), HF184 (AAA-GGG-ATG-
GA-TGA-GGA-G, pos. 2134 in 488R, rev.), and HF653
t(
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176 THURAU ET AL.(CCC-TAT-GTC-TTC-AAG-TTC-TAC-ACT-ATC-AG, pos. 2611
in 488R, rev.). Northern blots were hybridized either with
a random-primed double-stranded orf50b DNA probe or
with single-stranded RNA probes prepared by in vitro
transcription of the orf50b plasmid with SP6 or T7 RNA
polymerase. For RNase protection experiments, a tem-
plate plasmid was generated by cloning an 822-bp PCR
product exactly upstream of the orf50a splice donor site
into pCRII (Invitrogen). A radioactive antisense riboprobe
of 976 nt was generated using SP6 RNA polymerase,
32P-UTP, and the template plasmid after NotI lineariza-
tion. Total cellular RNA (40 mg each) was hybridized to
he riboprobe (250,000 cpm in 10 ml) at 37°C. After
digestion with the RNases A and T1, the protected frag-
ments were purified and visualized by autoradiography
after separation on a sequencing gel. In vitro transcrip-
tion and translation assays were performed in the pres-
ence of 35S-methionine, using T7 polymerase and a re-
ticulocyte lysate kit from Promega.
Cell culture and transfections
Permissive owl monkey kidney cells (OMK) were cul-
tivated and infected with HVS according to standard
protocols (Fickenscher and Fleckenstein, 1998). OMK
cells were transfected in triplicates with transactivator
and reporter plasmids (2 mg each), using lipofectamine
Gibco) according to published protocols (Whitehouse et
l., 1997a). The transactivation experiments were re-
eated twice and yielded similar results. CAT enzyme
ctivity was measured by quantitative autoradiography of
ilica chromatography plates. The T-cell lines CB-15
CD41; Biesinger et al., 1992) and 3C (CD81; Ficken-
cher et al., 1996) were grown in the presence of inter-
eukin-2 under standard conditions (Fickenscher and
leckenstein, 1998).
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